Adam Taylor
@adamjtaylor.bsky.social
Director of Cancer Biology at Sage Bionetworks. Building radically collaborative cancer research communities through team science and the integration of clinical, multiomic, single-cell, & spatial data with the HTAN DCC, MC2 Center, & AACR Project GENIE.
👏 Huge thanks to everyone at @sagebio.bsky.social , @mskcancercenter.bsky.social , @isbscience.org , @danafarber.bsky.social and across the HTAN community who made this possible—especially Ino and Milen, who led the charge and brought it all together.
March 31, 2025 at 9:13 PM
👏 Huge thanks to everyone at @sagebio.bsky.social , @mskcancercenter.bsky.social , @isbscience.org , @danafarber.bsky.social and across the HTAN community who made this possible—especially Ino and Milen, who led the charge and brought it all together.
📚 The paper also covers:
• Data standards and governance
• Infrastructure choices
• Community engagement strategies
• Lessons for others coordinating complex biomedical data at scale
• Data standards and governance
• Infrastructure choices
• Community engagement strategies
• Lessons for others coordinating complex biomedical data at scale
March 31, 2025 at 9:10 PM
📚 The paper also covers:
• Data standards and governance
• Infrastructure choices
• Community engagement strategies
• Lessons for others coordinating complex biomedical data at scale
• Data standards and governance
• Infrastructure choices
• Community engagement strategies
• Lessons for others coordinating complex biomedical data at scale
🔐 The portal points users to federated data destinations. Controlled-access data is available through the Cancer Research Data Commons (with dbGaP approval). Open-access datasets can be downloaded via Sage’s Synapse platform.
March 31, 2025 at 9:10 PM
🔐 The portal points users to federated data destinations. Controlled-access data is available through the Cancer Research Data Commons (with dbGaP approval). Open-access datasets can be downloaded via Sage’s Synapse platform.
🔍 The HTAN Portal is the central hub for exploring and accessing HTAN data. It offers intuitive, facet-based search, visualizations of imaging datasets, and links to curated views of imaging, single cell and clinical data in Minerva, CellxGene and cBioPortal
humantumoratlas.org
humantumoratlas.org
NCI Human Tumor Atlas Network
humantumoratlas.org
March 31, 2025 at 9:09 PM
🔍 The HTAN Portal is the central hub for exploring and accessing HTAN data. It offers intuitive, facet-based search, visualizations of imaging datasets, and links to curated views of imaging, single cell and clinical data in Minerva, CellxGene and cBioPortal
humantumoratlas.org
humantumoratlas.org
🛠️ The DCC built infrastructure to ingest, harmonize, and share data—backed by the Synapse platform and made explorable through the MSK-built HTAN Portal. We’re already putting this system to use for HTAN Phase 2!
humantumoratlas.org
humantumoratlas.org
NCI Human Tumor Atlas Network
humantumoratlas.org
March 31, 2025 at 9:08 PM
🛠️ The DCC built infrastructure to ingest, harmonize, and share data—backed by the Synapse platform and made explorable through the MSK-built HTAN Portal. We’re already putting this system to use for HTAN Phase 2!
humantumoratlas.org
humantumoratlas.org
🧬 Data from the first phase of HTAN is now available:
• 8,425 biospecimens
• 2,042 research participants
• 20+ molecular assays
All generated to study transitions in space and time from precancerous states to advanced disease.
• 8,425 biospecimens
• 2,042 research participants
• 20+ molecular assays
All generated to study transitions in space and time from precancerous states to advanced disease.
March 31, 2025 at 9:04 PM
🧬 Data from the first phase of HTAN is now available:
• 8,425 biospecimens
• 2,042 research participants
• 20+ molecular assays
All generated to study transitions in space and time from precancerous states to advanced disease.
• 8,425 biospecimens
• 2,042 research participants
• 20+ molecular assays
All generated to study transitions in space and time from precancerous states to advanced disease.